medigraphic.com

2022, Number 2

<< Back Next >>

Enf Infec Microbiol 2022; 42 (2)

Lyme borreliosis with neurological involvement: case report

Espinosa SMC, Almonte DAE, Juárez JCA, Suárez MM, Reyes GU, Reyes HKL, Alonso PNC, Reyes HMU, Baeza CJA, Juárez CCE

Language: Spanish
References: 21
Page: 77-81
PDF size: 220.40 Kb.


ABSTRACT

Lyme disease is a multisystem pathology with dermatological, rheumatological, cardiovascular and neurological clinical manifestations.
Clinical case. A 17-year-old female resident of Mexico City who was admitted with intracranial hypertension data of 72 hours of evolution accompanied by sudden-onset right strabismus. Tomography reports optic neuritis and hyperintense lesions in white matter. In her evolution, she presented secondary hydrocephalus, as well as subarachnoid hemorrhage and herniation. Within her approach, Lyme disease was considered, which was confirmed with positive igg by Western blot for Borrelia burgdorferi sensu lato. Her evolution was rapidly progressive, with a fatal outcome.
Conclusions. Neuroborreliosis is one of the many clinical spectrums that Lyme disease has. It should be investigated in patients with acute neurological disorders.


REFERENCES

  1. Sood, S.K., “Lyme disease in children”, Infect Dis ClinNorth Am, 2015, 29 (2): 281-294. Disponible en: http://dx.doi.org/10.1016/j.idc.2015.02.011.

  2. Shapiro, E.D., Borrelia burgdorferi (Lyme disease), PrincPract Pediatr Infect Dis, 2017: 976-977.

  3. Pachner, A.R. y Steere, A.C., “The triad of neurologicmanifestations of Lyme disease”, Neurology, 1985, 35(1): 47-53.

  4. Halperin, J.J., “Nervous system Lyme disease”, InfectDis Clin North Am, 2015, 29 (2): 241-253. Disponible en:http://dx.doi.org/10.1016/j.idc.2015.02.002.

  5. Mead, P.S., “Epidemiology of Lyme disease”, Infect DisClin North Am, 2015, 29 (2): 187-210. Disponible en: http://dx.doi.org/10.1016/j.idc.2015.02.010.

  6. Fahrer, H., Van der, L., Sauvain, M., Gern, L., Zhioua, E. yAeschliman, A., “The prevalence and incidence of clinicaland asymptomatic Lyme borreliosis in a populationat risk”, J Infect Dis, 1991, 163: 305-310.

  7. Hoffmann, A., “Monografía de los Ixodoidea de México”,Rev Soc Mex Hist Nat, 1962, xxiii: 197-282.

  8. Gordillo-Pérez, G., Torres, J., Solórzano, S.F., Cedillo, R.,Tapia, C. y Muñoz, O., “Serologic evidences suggestingthe presence of Borrelia burgdorferi infection in Mexico”,Arch Med Res, 1999, 30: 64-68.

  9. Gordillo-Pérez, G., Torres, J., Solórzano, S.F., Garduño,B.V., Tapia, C.R. y Muñoz, O., “Estudio seroepidemiológicode borreliosis de Lyme en la Ciudad de México y elnoreste de la República Mexicana”, Salud Publica Mex,2003, 45 (5): 351-355.

  10. García, L.F., “Enfermedad de Lyme adquirida en el estadode Morelos, México”, Med Interna México, 2018, 34(2): 342-348.

  11. Rožič, M., Lah, L.L., Ružić-Sabljić, E., Kastrin, A. y Arnež,M., “Lyme neuroborreliosis in children: etiology andcomparison of clinical findings of Lyme neuroborreliosiscaused by Borrelia garinii and Borrelia afzelii”, PediatrInfect Dis J, 2019, 38 (11): e279-284.

  12. Campo, C.D., Muñoz, L.A., De Eulate, G.F.G., Rodríguez,A.J., Gabilondo, A., González, F. et al., “Encefalomielitisextensa por borrelia: una forma atípica de neuroborreliosis”,Rev Neurol, 2019, 68 (4): 169-170.

  13. Celik, T., Celik, U., Kömür, M., Tolunay, O., Yildizdas, R.D.,Yagci-Kupeli, B. et al., “Pediatric Lyme neuroborreliosis:different clinical presentations of the same agent; singlecenter experience”, Neuro Endocrinol Lett, 2016, 37(2): 107-113.

  14. Sisalima, J.C., Galarza, D.R., Moreno, D.C., Gómez, D.M.y Dueñas, G., “Neuroborreliosis como causa”, 2013, 21(3): 108-114.

  15. Gordillo-Pérez, G., Solórzano, F., Cervantes, C.A., Sán-chez, V.G., García, R.R., Díaz, A.M. et al., “Lyme neuroborreliosisis a severe and frequent neurological diseasein Mexico”, Arch Med Res, 2018, 49 (6): 399-404.

  16. Gordillo-Pérez, G., García, J.I., Solórzano, S.F., Corrales,Z.L., Muñoz, H.O. y Torres, L.J., “Serological evidence ofBorrelia burgdorferi infection in Mexican patients withfacial palsy”, Rev Investig Clínica, 2017, 69 (6): 344-348.

  17. García, J.C. y Benach, J.L., “Lyme neuroborreliosis: clinicaloutcomes, controversy, pathogenesis, and polymicrobialinfections”, Ann Neurol, 2019, 85 (1): 21-31.

  18. Blanco, V.M.J., Guio, C.L., Montejo, J.M. e Iraurgu, A.P.,“Neuroborreliosis: experiencia de 10 años en un hospitalterciario del norte de España”, Rev Española Quimioter,2017, 30 (3): 234-235. Disponible en: https://medes.com/publication/122555.

  19. Hansen, K., Crone, C. y Kristoferitsch, W., “Lyme neuroborreliosis”,Handbook of clinical neurology, vol. 115, 1ªed., Elsevier, 2013, pp. 559-575. Disponible en: http://dx.doi.org/10.1016/B978-0-444-52902-2.00032-1.

  20. Gómez, E.M., Gómez, C.J., Calvo, P.L. y Oteo, J.A.,“Neuroborreliosis: serie de 7 casos en un hospital”,Neurología, 2016, 31 (2): 137-139.

  21. Lindland, E.S., Solheim, A.M., Andreassen, S.,Quist-Paulsen, E., Eikeland, R. y Beyer, M.K., “Imagingin Lyme neuroborreliosis apparent diffusion coefficientai, antibody index; Bb, Borrelia burgdorferi; clippers, cenhancementresponsive to steroids; cns, central nervoussystem, csf; cerebrospinal fluid efns, European Federationof Neurological Societies, fl”, 2018, 833-844. Disponibleen: https://doi.org/10.1007/s13244-018-0646-x.




2020     |     www.medigraphic.com